(NP (NP (NP Transcriptional/JJ analysis/NN) (PP of/IN (NP (NP Epstein-Barr/JJ virus/NN gene/NN expression/NN) (PP in/IN (NP EBV-positive/JJ gastric/JJ carcinoma/NN)))) :/:) (NP (NP unique/JJ viral/JJ latency/NN) (PP in/IN (NP the/DT tumour/NN cells/NNS)) ./.))
(S (SBAR Although/IN (S (NP-SBJ (NP case-oriented/JJ evidence/NN) (PP for/IN (NP (NP an/DT association/NN) (PP of/IN (NP (NP Epstein-Barr/JJ virus/NN) (PRN -LRB-/-LRB- (NP EBV/NN) -RRB-/-RRB-))) (PP with/IN (NP gastric/JJ carcinoma/NN))))) (VP has/VBZ (VP been/VBN (VP accumulating/VBG (ADVP-TMP recently/RB)))))) ,/, (NP-SBJ (NP the/DT interaction/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (PP between/IN (NP-COOD (NP EBV/NN) and/CC (NP gastric/JJ epithelial/NN cells/NNS)))) (VP is\/are/VBP (ADJP-PRD largely/RB unknown/JJ)) ./.)
(S (PP In/IN (NP this/DT study/NN)) ,/, (NP-SBJ we/PRP) (VP (VP examined/VBD (NP seven/CD EBV-positive/JJ gastric/JJ carcinoma/NN tissues/NNS) (PP for/IN (NP (NP viral/JJ gene/NN expression/NN) (PP at/IN (NP the/DT mRNA/NN level/NN))))) ,/, (SBAR (WHPP-61 from/IN (WHNP which/WDT)) (S (NP-SBJ (NP studies/NNS) (PP on/IN (NP (NP the/DT EBV/NN oncogenicity/NN) (PP in/IN (NP human/JJ epithelial/JJ cells/NNS))))) (VP will/MD (VP benefit/VB (PP *T*-61/-NONE-)))))) ./.)
(S (NP-SBJ Reverse/JJ transcription-PCR/NN analysis/NN) (VP showed/VBD (SBAR that/IN (S (NP-SBJ (QP all/DT seven/CD) EBV-positive/JJ tumour/NN tissues/NNS) (ADVP constitutively/RB) (VP expressed/VBD (NP-COOD (NP (NP (NP EBV/NN nuclear/JJ antigen/NN) (PRN -LRB-/-LRB- (NP EBNA/NN) -RRB-/-RRB-)) 1/CD mRNA/NN) ,/, (CONJP but/CC not/RB) (NP EBNA2/NN mRNA/NN)))))) ./.)
(S (S (NP-SBJ-62 The/DT EBNA/NN transcription/NN) (VP was/VBD (VP initiated/VBN (NP *-62/-NONE-) (PP from/IN (NP (NP (NP one/CD) (PP of/IN (NP three/CD EBNA/NN promoters/NNS))) ,/, (NP Qp/NN))))) :/:) (S (PP by/IN (NP contrast/NN)) ,/, (NP-SBJ-COOD-63 both/CC (NP Cp/NN) and/CC (NP Wp/NN)) (VP were/VBD (ADJP-PRD silent/JJ) ,/, (S (NP-SBJ *-63/-NONE-) (ADVP thus/RB) (VP resulting/VBG (PP in/IN (NP (NP the/DT lack/NN) (PP of/IN (NP EBNA2/NN mRNA/NN)))))))) ./.)
(S (S (NP-SBJ-64 (NP (NP Latent/JJ membrane/NN protein/NN) (PRN -LRB-/-LRB- (NP LMP/NN) -RRB-/-RRB-)) 2A/NN mRNA/NN) (VP was/VBD (VP detected/VBN (NP *-64/-NONE-) (PP in/IN (NP (NP three/CD) (PP of/IN (NP seven/CD cases/NNS)))))) ;/:) (S (ADVP however/RB) ,/, (NP-SBJ-65 (NP-COOD neither/CC (NP LMP1/NN) nor/CC (NP LMP2B/NN)) mRNA/NN) (VP was/VBD (VP detected/VBN (NP *-65/-NONE-) (PP in/IN (NP (NP any/DT) (PP of/IN (NP (NP the/DT tumours/NNS) (VP tested/VBN (NP */-NONE-))))))))) ./.)
(S (NP-SBJ (NP Transcripts/NNS) (PP from/IN (NP (NP the/DT BamHI-A/NN region/NN) (PP of/IN (NP the/DT viral/JJ genome/NN))))) (VP were/VBD (ADJP-PRD detectable/JJ) (PP in/IN (NP all/DT cases/NNS))) ./.)
(S (NP-SBJ-COOD-66 (NP BZLF1/NN mRNA/NN) and/CC (NP (NP the/DT product/NN) ,/, (NP (NP an/DT immediate-early/JJ gene/NN) (PP for/IN (NP EBV/NN replication/NN))) ,/,)) (VP was/VBD not/RB (VP expressed/VBN (NP *-66/-NONE-) (PP in/IN (NP (NP any/DT) (PP of/IN (NP them/PRP)))) ,/, (S (NP-SBJ */-NONE-) (ADVP thereby/RB) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ the/DT tumour/JJ cells/NNS) (VP carried/VBD (NP EBV/NN genomes/NNS) (PP in/IN (NP a/DT (ADJP tightly/RB latent/JJ) form/NN))))))))) ./.)
(S (NP-SBJ These/DT findings/NNS) (VP-COOD (VP (ADVP further/RB) extended/VBD (NP (NP our/PRP$ previous/JJ data/NNS) (PP regarding/VBG (NP (NP EBV/NN latency/NN) (PP in/IN (NP gastric/JJ carcinoma/NN cells/NNS)) (PP at/IN (NP the/DT protein/NN level/NN)))))) ,/, and/CC (VP have/VBP (VP affirmed/VBN (SBAR that/IN (S (NP-SBJ (NP the/DT programme/NN) (PP of/IN (NP (NP viral/JJ gene/NN expression/NN) (PP in/IN (NP the/DT tumour/NN))))) (VP (ADVP (ADVP more/RBR closely/RB) (PP *ICH*-67/-NONE-)) resembles/VBZ (NP '/`` (NP latency/NN I/CD) '/'' (VP represented/VBN (NP */-NONE-) (PP by/IN (NP-LGS (NP Burkitt/NN) 's/POS)))) (PP-67 lymphoma/NN (NP than/IN (NP '/`` latency/NN) II/CD (VP '/'' (NP */-NONE-) (PP represented/VBN (NP-LGS (NP by/IN the/DT) (PP majority/NN (NP of/IN nasopharyngeal/JJ))))))))))))) carcinomas/NNS)
